Drugs / ES135
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03229031 | Mar 2018 → Dec 2024 | spinal cord injury | Eusol Biotech Co., Ltd. | Suspended | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ES135 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03229031 ↗ |
| Route | Intrathecal | “administered via intrathecal” NCT03229031 ↗ |